Related references
Note: Only part of the references are listed.Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Thomas Reinert et al.
GUT (2016)
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA
G. Gremel et al.
ANNALS OF ONCOLOGY (2016)
EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method
Kana Watanabe et al.
CANADIAN RESPIRATORY JOURNAL (2016)
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
L. Saadatpour et al.
CANCER GENE THERAPY (2016)
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang J. Janni et al.
CLINICAL CANCER RESEARCH (2016)
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA.
Oliver A. Zill et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Karen L. Reckamp et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
HER2 expression identifies dynamic functional states within circulating breast cancer cells
Nicole Vincent Jordan et al.
NATURE (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
BARHL2 Methylation Using Gastric Wash DNA or Gastric Juice Exosomal DNA is a Useful Marker For Early Detection of Gastric Cancer in an H-pylori-Independent Manner
Hiroyuki Yamamoto et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
Bee Luan Khoo et al.
SCIENCE ADVANCES (2016)
21PD_PR * PERCEPTION OF LUNG CANCER (LC) RISK: IMPACT OF SMOKING STATUS AND NICOTINE DEPENDENCE
L. Greillier et al.
ANNALS OF ONCOLOGY (2015)
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
L. Barault et al.
ANNALS OF ONCOLOGY (2015)
96O * DETERMINING THE PREVALENCE OF EGFR MUTATIONS IN ASIAN AND RUSSIAN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG CANCER (ANSCLC) OF ADENOCARCINOMA (ADC) AND NON-ADC HISTOLOGY: IGNITE STUDY
B. Han et al.
ANNALS OF ONCOLOGY (2015)
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M. P. Morelli et al.
ANNALS OF ONCOLOGY (2015)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Tumor-Educated Platelets as Liquid Biopsy in Cancer Patients
Simon A. Joosse et al.
CANCER CELL (2015)
Epidermal Growth Factor Receptor Mutation Status in Cell-Free DNA Supernatant of Bronchial Washings and Brushings
Akihiko Kawahara et al.
CANCER CYTOPATHOLOGY (2015)
Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Laure Cayrefourcq et al.
CANCER RESEARCH (2015)
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
Sabrina Arena et al.
CLINICAL CANCER RESEARCH (2015)
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Tony Mok et al.
CLINICAL CANCER RESEARCH (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients
Johnny C. Akers et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
Kenneth S. Thress et al.
LUNG CANCER (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna et al.
NATURE MEDICINE (2015)
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Yuxuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
Gaia Schiavon et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Accessing Genetic Information with Liquid Biopsies
Xuyu Cai et al.
TRENDS IN GENETICS (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
Muhammed Murtaza et al.
NATURE COMMUNICATIONS (2015)
Characterization of DNA Methylation in Circulating Tumor Cells
Constantin F. Pixberg et al.
GENES (2015)
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Niki Karachaliou et al.
JAMA ONCOLOGY (2015)
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
Jian Zhang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2015)
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
Shigeshi Ono et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
Mantang Qiu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Quantitative Cell-Free Circulating BRAF(V600E) Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
Miguel F. Sanmamed et al.
CLINICAL CHEMISTRY (2015)
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman et al.
PLOS ONE (2015)
Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA
Luis A. Diaz et al.
Oncotarget (2015)
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
Erina Takai et al.
SCIENTIFIC REPORTS (2015)
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Richard J. Lobb et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Alison S. Devonshire et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
Britta Weber et al.
BMC CANCER (2014)
First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
J-Y Douillard et al.
BRITISH JOURNAL OF CANCER (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Caitlin Williams et al.
CELL RESEARCH (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Expression Profiling of Exosomal miRNAs Derived from Human Esophageal Cancer Cells by Solexa High-Throughput Sequencing
Juan Liao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer
Christoph Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors
Nardin Samuel et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
Florent Mouliere et al.
MOLECULAR ONCOLOGY (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Alain R. Thierry et al.
NATURE MEDICINE (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines
A. Q. Butt et al.
ONCOGENE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
Sandra Misale et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
Jie Luo et al.
SCIENTIFIC REPORTS (2014)
Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
Kyongchol Kim et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance
Giulia Siravegna et al.
GENOME BIOLOGY (2014)
International study on inter-reader variability for circulating tumor cells in breast cancer
Michail Ignatiadis et al.
BREAST CANCER RESEARCH (2014)
Stability of miRNA in human urine supports its biomarker potential
Christine Mall et al.
BIOMARKERS IN MEDICINE (2013)
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
K. C. Allen Chan et al.
CANCER (2013)
Biologic Challenges in the Detection of Circulating Tumor Cells
Simon A. Joosse et al.
CANCER RESEARCH (2013)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
Methylation of the hTERT Promoter: A Novel Cancer Biomarker for Leptomeningeal Metastasis Detection in Cerebrospinal Fluids
Stephanie Bougel et al.
CLINICAL CANCER RESEARCH (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Circulating Tumor Cells: Liquid Biopsy of Cancer
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2013)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion
Hye-Suk Han et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
Ellen Heitzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer
Akito Hata et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats
Dolores C. Garcia-Olmo et al.
MOLECULAR CANCER (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CEREBROSPINAL FLUID SECRETION BY THE CHOROID PLEXUS
Helle H. Damkier et al.
PHYSIOLOGICAL REVIEWS (2013)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
Florent Mouliere et al.
TRANSLATIONAL ONCOLOGY (2013)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli et al.
CANCER DISCOVERY (2013)
Circulating Tumor Cells and Circulating Tumor DNA
Catherine Alix-Panabieres et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Karen-Lise Garm Spindler et al.
CLINICAL CANCER RESEARCH (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
Medulloblastoma
Katja von Hoff et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls
Susan R. Sturgeon et al.
EPIGENETICS (2012)
Quantitative Measurement of Cell-Free Plasma DNA and Applications for Detecting Tumor Genetic Variation and Promoter Methylation in a Clinical Setting
Sunil K. Kadam et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA
Tomomi Nakamura et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitor
Amelie Clementine Seghers et al.
MELANOMA RESEARCH (2012)
The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
Alessia Gallo et al.
PLOS ONE (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer
Tingting Wang et al.
PLOS ONE (2012)
High Resolution Size Analysis of Fetal DNA in the Urine of Pregnant Women by Paired-End Massively Parallel Sequencing
Nancy B. Y. Tsui et al.
PLOS ONE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Differences in the quantity of DNA found in the urine and saliva of smokers versus nonsmokers: implications for the timing of epigenetic events
Melissa Simkin et al.
EPIGENOMICS (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges
Evi S. Lianidou et al.
CLINICAL CHEMISTRY (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Multiplex Amplification Coupled with COLD-PCR and High Resolution Melting Enables Identification of Low-Abundance Mutations in Cancer Samples with Low DNA Content
Coren A. Milbury et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Characterization of extracellular circulating microRNA
Andrey Turchinovich et al.
NUCLEIC ACIDS RESEARCH (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
K. Ameri et al.
BRITISH JOURNAL OF CANCER (2010)
Differential Methylation of Cell-Free Circulating DNA Among Patients With Pancreatic Cancer Versus Chronic Pancreatitis
Thomas Liggett et al.
CANCER (2010)
Circulating Tumor Cells in the Management of Breast Cancer
Govardhanan Nagaiah et al.
CLINICAL BREAST CANCER (2010)
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Henry K. Lin et al.
CLINICAL CANCER RESEARCH (2010)
Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors
David J. McBride et al.
GENES CHROMOSOMES & CANCER (2010)
Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes
Ji Eun Oh et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Exosomes: Extracellular organelles important in intercellular communication
Suresh Mathivanan et al.
JOURNAL OF PROTEOMICS (2010)
Overdiagnosis in Cancer
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Y. M. Dennis Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Circulating tumour cells: their utility in cancer management and predicting outcomes
Matthew G. Krebs et al.
Therapeutic Advances in Medical Oncology (2010)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment
Lasse Sommer Kristensen et al.
CLINICAL CHEMISTRY (2009)
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Guilherme Rabinowits et al.
CLINICAL LUNG CANCER (2009)
Exosomes - vesicular carriers for intercellular communication
Mikael Simons et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer
Joerg Ellinger et al.
JOURNAL OF UROLOGY (2009)
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Wenjun Zhou et al.
NATURE (2009)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Shedding microvesicles: artefacts no more
Emanuele Cocucci et al.
TRENDS IN CELL BIOLOGY (2009)
Transrenal nucleic acids: From proof of principle to clinical tests - Problems and solutions
Hovsep S. Melkonyan et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
M. Frattini et al.
CANCER LETTERS (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients
Frank Diehl et al.
GASTROENTEROLOGY (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer
Joerg Ellinger et al.
PROSTATE (2008)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
Circulating (cell-free) nucleic acids - A promising, non-invasive tool for early detection of several human diseases
Vishnu Swarup et al.
FEBS LETTERS (2007)
EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib
H. Kimura et al.
BRITISH JOURNAL OF CANCER (2006)
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer
Junichi Soh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer
Hideharu Kimura et al.
CLINICAL CANCER RESEARCH (2006)
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence:: A prospective study
Emmanuelle Gormally et al.
CANCER RESEARCH (2006)
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Frank Diehl et al.
NATURE METHODS (2006)
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles
Eva Wieckowski et al.
IMMUNOLOGIC RESEARCH (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins
H Fujiwara et al.
CLINICAL CANCER RESEARCH (2005)
RNA profiling of cell-free saliva using microarray technology
Y Li et al.
JOURNAL OF DENTAL RESEARCH (2004)
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics
T El-Hefnawy et al.
CLINICAL CHEMISTRY (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer
MO Hoque et al.
CANCER RESEARCH (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
YH Su et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Changes in concentration of DNA in serum and plasma during storage of blood samples
M Jung et al.
CLINICAL CHEMISTRY (2003)
Effects of blood-processing protocols on cell-free DNA quantification in plasma
DW Swinkels et al.
CLINICAL CHEMISTRY (2003)
Quantification of free circulating DNA as a diagnostic marker in lung cancer
G Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
DNA alterations in body fluids as molecular tumor markers for urological malignancies
C Goessl et al.
EUROPEAN UROLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
